Interest of HI-RTE Elasticity in Obstetric
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01032564|
Recruitment Status : Completed
First Posted : December 15, 2009
Last Update Posted : August 29, 2014
In obstetric, the investigators can't predict accurately with current means (BISHOP score, traditional cervix ultrasonography and fibronectin) the childbirth time and delay.
If ultrasonography can determine the length, the cervix opening, it can't define its flexibility. Indeed, the conventional cervix ultrasonography can't inform us about the consistency of the uterine cervix.
The elastography (elasticity imagery) is an innovating technology. It is a new technology currently used as part of breast cancer estimate. This diagnosis mean use the ultrasonography to measure the tissues answer under pressure.
Its contribution in obstetric must be estimated to improve patients minimum fare.
The main target of the investigators study is to estimate the interest of the measure of cervix elasticity degree by elastography in prediction of premature birth within a population of pregnant women
|Condition or disease||Intervention/treatment||Phase|
|Premature Birth||Other: The elastography (elasticity imagery)||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||73 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Study Start Date :||December 2009|
|Actual Primary Completion Date :||July 2013|
|Actual Study Completion Date :||July 2013|
- Other: The elastography (elasticity imagery)
This diagnosis mean use the ultrasonography to measure the tissues answer under pressure
- The elastography (elasticity imagery) [ Time Frame: 18 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01032564
|Assistance Publique Hopitaux de Marseille|
|Marseille, France, 13|
|Principal Investigator:||Florence BRETELLE||Assistance Publique Hopitaux De Marseille|